The research, published in Frontiers in Psychiatry, followed 308 patients diagnosed with pulmonary nodules at a hospital in Urumqi, China, between January 2023 and January 2026. All participants completed questionnaires within one month of their nodules being spotted on chest CT, at a point when the nature of the growth remained undetermined and no pathological diagnosis had been made. The team, led by Shanshan Wu and colleagues at the Xinjiang Production and Construction Corps Hospital, set out to test a specific theoretical chain: that uncertainty about malignancy risk first shapes a patient’s illness perception, which then drives ruminative thinking, which in turn amplifies anxiety.

Pulmonary nodules have become an increasingly common finding as low-dose CT screening for lung cancer spreads and public health awareness grows. A 2024 meta-analysis cited in the study estimated that roughly 27 percent of people worldwide carry these nodules, with prevalence slightly higher in men. In China, an epidemiological survey put the figure at approximately 55.9 percent. Because imaging features alone cannot quickly rule out malignancy, most patients must endure follow-up scans and further differential diagnosis — sometimes for months or years — while the true nature of their nodule remains unknown.

To capture this psychological landscape, the researchers used four validated instruments. Uncertainty about malignant risk was measured with a revised version of the Mishel Uncertainty in Illness Scale, adapted specifically for pulmonary nodule patients through translation, back-translation, cognitive interviews, and expert review. Illness perception was assessed with the Brief Illness Perception Questionnaire, ruminative thinking with the Chinese version of the Ruminative Responses Scale, and anxiety with the seven-item Generalized Anxiety Disorder scale, or GAD-7. All four scales showed acceptable internal consistency in this sample, with Cronbach’s alpha values ranging from 0.831 to 0.904.

The numbers told a striking story. Uncertainty scores averaged 56.10 on a scale where higher values indicate greater distress about malignant potential — a mid-to-high level suggesting most patients experienced substantial unease. Illness perception scores averaged 43.26 out of 80, indicating generally negative views of the condition. Rumination scores averaged 44.66, and GAD-7 anxiety scores averaged 8.84 — squarely in the mild anxiety range, but close to the threshold for moderate anxiety. Notably, anxiety levels did not differ significantly by age, sex, education, income, smoking history, nodule size, location, density, or family history of lung cancer, suggesting the uncertainty itself, rather than any demographic or clinical characteristic, was the dominant driver of distress.

Pearson correlation analysis confirmed that all four variables moved together. Uncertainty scores correlated positively with illness perception (r = 0.687), rumination (r = 0.577), and anxiety (r = 0.745). Illness perception correlated with rumination (r = 0.577) and anxiety (r = 0.601), and rumination correlated with anxiety (r = 0.574). These were moderate to strong associations, and they set the stage for the study’s central analysis: a serial mediation model testing whether illness perception and rumination formed a sequential bridge between uncertainty and anxiety.

Using the PROCESS macro (Model 6) in SPSS, with 5,000 bootstrap resamples and eleven covariates controlled — including age, sex, education, marital status, income, smoking and drinking history, nodule count, location, density, and family history of lung cancer — the team found that the direct effect of uncertainty on anxiety accounted for 75.63 percent of the total effect. But the remaining quarter flowed through three indirect pathways. Uncertainty influenced anxiety through rumination alone (8.75 percent of the total effect), through illness perception alone (10.00 percent), and through the full serial chain of illness perception followed by rumination (5.62 percent). All confidence intervals excluded zero, confirming statistical significance.

The serial pathway is the most theoretically interesting finding. It suggests that when patients cannot determine whether their nodule is cancerous, they first construct a negative cognitive representation of their illness — overestimating severity, underestimating personal control, and attributing vague symptoms like cough or chest tightness to malignant disease. That negative perception then narrows attention toward threat-related cues and fuels repetitive, unproductive thinking about causes and consequences. Rumination, in turn, reinforces the negative illness beliefs, creating a self-perpetuating cycle that the authors describe as a loop between uncertainty, perception, rumination, and anxiety.

The neurobiological context, while not directly measured in this study, offers a plausible mechanism. Prior research has linked uncertainty under threat to hyperactivation of the amygdala and impaired executive control by the prefrontal cortex, and rumination has been associated with overactivation of the default mode network alongside reduced dorsolateral prefrontal function. The authors are careful to note that these mechanisms remain speculative in the context of their data, since no neurobiological indicators were collected. Still, the pattern is consistent with a broader literature showing that ambiguous, unresolvable threats — unlike definitive diagnoses — keep the threat-detection system in a state of sustained arousal.

The clinical implications are concrete. The authors argue that clinicians should not focus solely on the physical management of nodules but should actively address the psychological dimension. Providing clear, accurate information about nodule nature, malignancy risk, and follow-up plans could reduce uncertainty at the source. Cognitive behavioral therapy may help patients identify and restructure maladaptive illness beliefs, while mindfulness training and attentional redirection could interrupt ruminative loops before they harden into chronic anxiety. Given that mental health problems among nodule patients can drive excessive healthcare utilization and unnecessary resource consumption, the authors see targeted psychological intervention not as a luxury but as a practical public health measure.

The study’s limitations are acknowledged candidly. The cross-sectional design means all variables were measured at roughly the same time, so the serial pathway reflects associations consistent with the hypothesized model rather than proven causation. Alternative sequences — such as rumination preceding illness perception — cannot be ruled out with this data. The single-center sample may limit generalizability, self-report measures carry recall and social desirability bias, and the adapted uncertainty scale requires further psychometric validation. Longitudinal and multicenter studies, the authors say, are needed to confirm the temporal dynamics and to test whether interventions targeting illness perception and rumination can actually break the cycle.

Subject of Research: Psychological pathway linking pulmonary nodule malignancy-risk uncertainty to anxiety via illness perception and rumination

Article Title: Association between uncertainty regarding malignant risk and anxiety in patients with pulmonary nodules: a serial mediation analysis of illness perception and rumination

Article References: Wu, S., Liu, M., Yi, S., Wang, R., Song, Z., Xie, F., Chen, W., Qu, H., & Huang, Y. (2026). Association between uncertainty regarding malignant risk and anxiety in patients with pulmonary nodules: a serial mediation analysis of illness perception and rumination. Frontiers in Psychiatry, 17, Article 1957701. https://doi.org/10.3389/fpsyt.2026.1957701

Image Credits: AI Generated

DOI: 10.3389/fpsyt.2026.1957701

Keywords: pulmonary nodules, anxiety, illness perception, rumination, uncertainty, serial mediation, lung cancer screening, psychiatry, cognitive behavioral therapy, CT screening, health psychology, Frontiers in Psychiatry